Bayer: all 1,694 studies
Page 17 of 17. Open to participants first (61), then studies with results posted, then the rest; newest registration first within each.
- Valette (Combined Oral Contraceptive SH T04769G and SH D00659AF) Low Ovulation InhibitionCompletedNCT00471991Phase 2
- The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial HypertensionCompletedNCT00471003
- Assessment of Compliance With Antihypertensive Telmisartan TherapyCompletedNCT00470886
- Vardenafil Treatment Of Erectile Dysfunction In Depressive And Non-Depressive MenCompletedNCT00470873
- Efficacy of Gynodian® Depot in Women With Impaired Well-beingCompletedNCT00463450Phase 3
- FDA Phase IV - Commitment - Retinal Function StudyCompletedNCT00461565Phase 4
- Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With BetaseronCompletedNCT00461396
- A Placebo-controlled Phase II Study of Bone-targeted Radium-223 in Symptomatic Hormone-refractory Prostate CancerCompletedNCT00459654Phase 2
- An Open Multiple Dose Titration Study In Patients With Pulmonary HypertensionCompletedNCT00454558Phase 2
- Investigation of Mass Balance of the Test Drug and Major MetabolitesCompletedNCT00432302Phase 1
- Efficacy and Safety of Sequential IV/PO Moxifloxacin in Comparison to IV Levofloxacin Plus IV Ceftriaxone Followed by PO Levofloxacin, in the Treatment of Patients With Community-acquired PneumoniaCompletedNCT00431678Phase 3
- Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary HypertensionCompletedNCT00414687Phase 2
- Use of Nebido® to Assess Tolerability and Treatment Outcomes in Daily Clinical PracticeCompletedNCT00410306
- An Oral, Direct Factor Xa Inhibitor, BAY59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging StudyCompletedNCT00402467Phase 2
- Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip ReplacementCompletedNCT00398905Phase 2
- Dose-ranging Study of Once-daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip ReplacementCompletedNCT00396786Phase 2
- Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein ThrombosisCompletedNCT00395772Phase 2
- Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of MenorrhagiaCompletedNCT00393198Phase 4
- Levitra (Vardenafil, BAY38-9456) Partner Satisfaction Study IICompletedNCT00377793Phase 4
- Dose Escalation Study of SH U04722 in Solid TumorsTerminatedNCT00375453Phase 1
- Study to Evaluate the Effect of Six Cycles of Treatment With a Combined Oral Contraceptive (EE 0.30 mg/DRSP 3 mg) on Quality of Life.CompletedNCT00367276Phase 3
- Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). A Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement.CompletedNCT00361894Phase 3
- A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung CancerCompletedNCT00359359Phase 1/2
- Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.CompletedNCT00356447Phase 3
- Phase IV Randomization to On-Going Treatment to Evaluate Sustained SorafenibTerminatedNCT00352859Phase 4
- ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate CancerCompletedNCT00350051Phase 2
- BAY88-8223, Dose Finding Study in Patients With HRPCCompletedNCT00337155Phase 2
- Fat Distribution in Healthy Early Postmenopausal WomenCompletedNCT00335218Phase 4
- Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE, a Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip ReplacementCompletedNCT00332020Phase 3
- Rivaroxaban (10mg) Given Once Daily in Patients Undergoing Total Hip Replacement Compared to EnoxaparinCompletedNCT00329628Phase 3
- Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Elective Spinal Fusion SurgeryTerminatedNCT00327379Phase 3
- ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian CancerCompletedNCT00325351Phase 2
- Impact of SH T00658ID as Compared to a Monophasic Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D01155E) on Hemostatic ParametersCompletedNCT00318799Phase 2
- Study to Compare Double-dose Betaferon to the Approved Dose, for Patients With Early Secondary Progressive Multiple Sclerosis (SPMS)WithdrawnNCT00313976Phase 3
- Evaluation of a New Agent for Treatment of Advanced Stage Breast CancerCompletedNCT00313248Phase 2
- Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Aortic Arch and Cerebral BranchesCompletedNCT00310609Phase 3
- Cardiovascular Safety Study of Magnevist® Injection at Two Dose Levels and Two Injection Rates in Normal SubjectsCompletedNCT00310596Phase 1
- Magnevist® Injection-enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis of the Renal ArteriesCompletedNCT00310557Phase 3
- Depiction of Delayed Enhancement in Patients With Documented Myocardial InfarctionCompletedNCT00310544Phase 2
- 3-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal WomenCompletedNCT00310531Phase 3
- Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis in the Calf and/or Pedal ArteriesCompletedNCT00309075Phase 3
- Identification of Hepatic LesionsCompletedNCT00307866Phase 3
- Efficacy and Safety of Aprotinin on Transfusion Requirements in Patients Undergoing Radical or Total CystectomyTerminatedNCT00306150Phase 3
- Study to Investigate the Effect of Aprotinin of Transfusion Requirements in Patients Undergoing Surgical Procedures for Lung or Esophageal CancerTerminatedNCT00306137Phase 3
- Bleeding Pattern StudyCompletedNCT00302666Phase 3
- Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung CancerTerminatedNCT00299390Phase 2
- Comparison Study of Vasovist® Magnetic Resonance Angiography (MRA) and an MRA With a Conventional Extracellular Contrast Agent With X-ray Angiography in Patients With Peripheral Artery DiseaseCompletedNCT00296855Phase 3
- Menorrhagia Study in Women With Treatment-resistant MenorrhagiaCompletedNCT00288691Phase 2
- Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast CancerCompletedNCT00288249Phase 2
- Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne PapulopustulosaCompletedNCT00280657Phase 3
- Effect of BAY 43-9006 (Sorafenib) on Cardiovascular Safety Parameters in Cancer PatientsCompletedNCT00259129Phase 1
- Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 YearsCompletedNCT00250640
- Efficacy and Safety Study of ZK219477 in Patients With Recurrent Ovarian CancerCompletedNCT00246688Phase 2
- Efficacy and Safety of SH T00660AA in Treatment of EndometriosisCompletedNCT00225199Phase 3
- Safety and Efficacy of SH T00660AA in Treatment of EndometriosisCompletedNCT00225186Phase 3
- Pearl Index Study With Low Dose Combined Oral ContraceptiveCompletedNCT00220324Phase 3
- Assessment of Long Term Treatment With Testosterone Undecanoate in Males With HypogonadismCompletedNCT00220298Phase 3
- Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's LymphomaCompletedNCT00220285Phase 2
- STEPS Trial - Spheramine Safety and Efficacy StudyTerminatedNCT00206687Phase 2
- An Efficacy and Safety Comparison Study of Two Marketed Drugs in Patients With Relapsing-remitting MSCompletedNCT00206648Phase 4
- Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple SclerosisCompletedNCT00206635
- Efficacy and Safety Study in Postmenopausal Women to Determine the Lowest Effective Dose for Relief of Moderate to Severe Hot-FlushesCompletedNCT00206622Phase 4
- Efficacy and Safety Study of an Oral Contraceptive in Healthy FemalesCompletedNCT00206583Phase 3
- Efficacy and Safety Oral Contraceptive StudyCompletedNCT00185484Phase 3
- A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring ContraceptionCompletedNCT00185419Phase 3
- Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Treatment in Patients With Follicular Non Hodgkin Lymphoma (Stage III or IV) Having Achieved a Partial or Complete Remission After First Line ChemotherapyCompletedNCT00185393Phase 3
- Comparative Cycle Control EuropeCompletedNCT00185367Phase 3
- FC Patch Comparator StudyCompletedNCT00185354Phase 3
- Study to Investigate the Efficacy of a Non-hormonal Drug Against Endometriosis Associated Pelvic PainCompletedNCT00185341Phase 2
- Efficacy and Tolerability of Angeliq in Thai WomenCompletedNCT00185328Phase 4
- Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary HypertensionCompletedNCT00185315Phase 3
- Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic MelanomaCompletedNCT00185302Phase 2
- Study to Investigate Efficacy and Safety of a New Oral ContraceptiveCompletedNCT00185289Phase 3
- Magnevist® Injection Enhanced MRA at Two Dose Levels Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Infrarenal Aorta and Peripheral ArteriesCompletedNCT00185276Phase 3
- Betaferon/ Betaseron (Interferon Beta-1b) in Patients With Chronic Viral CardiomyopathyCompletedNCT00185250Phase 2
- Treatment of Hot Flushes in Asian Women With Ultra-low Dose Estradiol PatchCompletedNCT00185237Phase 3
- Metabolism Study to Investigate the Impact of a Sequential Oral ContraceptiveCompletedNCT00185224Phase 2
- Efficacy and Safety of Testogel® in Men With Partial Androgen Deficiency of Aging Males (PADAM)CompletedNCT00185198Phase 3
- Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung CancerCompletedNCT00160069Phase 2
- Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer.CompletedNCT00160043Phase 2
- Study to Evaluate the Effect of Renal Function on the Single-Dose Pharmacokinetics of BAY 43-9006CompletedNCT00119639Phase 1
- Treatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell CarcinomaCompletedNCT00111020Phase 3
- Research Study for Patients With Metastatic Renal Cell CarcinomaTerminatedNCT00110344Phase 2
- Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive WomenCompletedNCT00102141Phase 3
- BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) PatientsCompletedNCT00099502Phase 3
- Fludarabine Combined With Either Alemtuzumab or Rituximab in Treating Patients With Refractory or Relapsed B-Cell Chronic Lymphocytic LeukemiaCompletedNCT00086775Phase 2
- Study of Nexavar (Sorafenib, BAY 43-9006) in Patients With Advanced Refractory CancerCompletedNCT00079612Phase 2
- Safety and Efficacy of BAY 50-4798 in Patients With HIV InfectionCompletedNCT00059462Phase 1/2
- Repinotan in Patients With Acute Ischemic StrokeCompletedNCT00044915Phase 2
- Evaluation of Bay 59-8862 in Patients With Advanced Renal Cell CarcinomaCompletedNCT00044564Phase 2
- Evaluation of Bay 59-8862 in Patients With Aggressive, Refractory Non-Hodgkin's LymphomaCompletedNCT00044551Phase 2
- Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer PatientsCompletedNCT00044538Phase 2
- Evaluation of BAY59-8862 in Taxane-Resistant Metastatic Breast Cancer PatientsCompletedNCT00044525Phase 2
- Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT RegimenCompletedNCT00002238Phase 3